SummaryBackgroundImmunocompromised patients with influenza are at higher risk of pneumonia and death. However, risk factors for progression to pneumonia still need evaluation.MethodsRetrospective study in immunocompromised patients with influenza-related respiratory infections. Risk factors for pneumonia were identified by multivariable logistic regression.ResultsWe identified 100 immunocompromised patients infected with influenza (68 hematological malignancies, 11 HIV, 21 iatrogenic immunosuppression). Immunofluorescence was positive in 95% of patients, mainly on nasopharyngeal aspirates (84%). Influenza A virus was involved in 80% of patients. Associated infection was documented in 34 patients. All patients presented with upper respirator...
Influenza virus infections (IVI) may pose a vital threat to immunocompromised patients such as those...
Recently, lymphocytopenia has been evaluated as an independent biomarker of mortality in hospitalize...
Yearly administration of the influenza vaccine is the main strategy to prevent influenza in immunoco...
BACKGROUND: It is unclear whether influenza infection and associated co-infection are associated wit...
BACKGROUND: The correct management of immunocompromised patients with pneumonia is debated. We evalu...
Abstract Objective To explore disease severity and risk factors for 30-day mortality of adult immuno...
BACKGROUND: The correct management of immunocompromised patients with pneumonia is debated. We evalu...
Objective: The risk factors and the impact of NAI treatments in patients with severe influenza A-ass...
BackgroundInfluenza and pneumonia combined are the leading causes of death due to infectious disease...
The emergence of new influenza virus subtypes has rekindled the interest in the clinical course and ...
Influenza virus infections (IVI) may pose a vital threat to immunocompromised patients such as those...
Recently, lymphocytopenia has been evaluated as an independent biomarker of mortality in hospitalize...
Yearly administration of the influenza vaccine is the main strategy to prevent influenza in immunoco...
BACKGROUND: It is unclear whether influenza infection and associated co-infection are associated wit...
BACKGROUND: The correct management of immunocompromised patients with pneumonia is debated. We evalu...
Abstract Objective To explore disease severity and risk factors for 30-day mortality of adult immuno...
BACKGROUND: The correct management of immunocompromised patients with pneumonia is debated. We evalu...
Objective: The risk factors and the impact of NAI treatments in patients with severe influenza A-ass...
BackgroundInfluenza and pneumonia combined are the leading causes of death due to infectious disease...
The emergence of new influenza virus subtypes has rekindled the interest in the clinical course and ...
Influenza virus infections (IVI) may pose a vital threat to immunocompromised patients such as those...
Recently, lymphocytopenia has been evaluated as an independent biomarker of mortality in hospitalize...
Yearly administration of the influenza vaccine is the main strategy to prevent influenza in immunoco...